(Q43577899)

English

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality

scientific article published in December 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Herman Waldmann

object named as

H Waldmann

7

0 references

8

object named as

Geoff Hale

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

12

object named as

David C Linch

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Anthony H. Goldstone

11

object named as

Anthony H Goldstone

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

2

object named as

Irit Avivi

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Panagiotis D Kottaridis

5

object named as

Panagiotis D Kottaridis

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Suparno Chakrabarti

1

object named as

Suparno Chakrabarti

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

10

object named as

Kwee Yong

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Stephen Mackinnon

3

object named as

Stephen Mackinnon

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

6

object named as

Husam Osman

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Christopher Fegan

9

object named as

Christopher D Fegan

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

author name string

Kate Ward

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Donald W Milligan

13

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

language of work or name

0 references

publication date

1 December 2002

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

119

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

1125-1132

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

Pre-emptive use of aerosolized ribavirin in the treatment of asymptomatic pediatric marrow transplant patients testing positive for RSV.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Patients with multiple myeloma may safely undergo autologous transplantation despite ongoing RSV infection and no ribavirin therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Non-myeloablative stem cell transplants

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: response to ribavirin therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Pre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory viral infections in immunocompetent and immunocompromised persons

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory viral infections in primary immune deficiencies: significance and relevance to clinical outcome in a single BMT unit

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Parainfluenza virus 3 infection after stem cell transplant: relevance to outcome of rapid diagnosis and ribavirin treatment

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Community respiratory viruses in individuals with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Epidemiological features of parainfluenza virus infections: laboratory surveillance in England and Wales, 1975-1997.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory disease due to parainfluenza virus in adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Community respiratory virus infections among hospitalized adult bone marrow transplant recipients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Community respiratory virus infections in immunocompromised patients with cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2002.03992.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2002.03992.X

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43577899&oldid=2101605500"